GCTK Glucotrack, Inc.

Nasdaq glucotrack.com


$ 5.22 $ 0.12 (2.25 %)    

Friday, 14-Nov-2025 12:53:08 EST
QQQ $ 608.63 $ 9.07 (1.51 %)
DIA $ 472.07 $ 0.65 (0.14 %)
SPY $ 671.79 $ 6.33 (0.95 %)
TLT $ 88.96 $ -0.83 (-0.93 %)
GLD $ 376.70 $ 3.81 (1.02 %)
$ 5.67
$ 5.10
$ 5.17 x 200
$ 5.30 x 100
$ 5.10 - $ 5.22
$ 4.22 - $ 468.00
9,566
na
5.16M
$ 3.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-21-2021 03-31-2021 10-Q
20 04-13-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-19-2020 03-31-2020 10-Q
24 04-14-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 04-15-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-30-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-16-2016 03-31-2016 10-Q
40 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 glucotrack-q3-eps-464-up-from-109-thousand-yoy

GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(4.64) per share. This is a 99.58 percent increase over losses of $(1.09...

 glucotrack-has-been-granted-us-patent-number-12453494-titled-methods-and-systems-for-measuring-glucose-having-improved-decay-rates-and-lag-times

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12453494).pn

 reported-september-12-2025-glucotrack-issues-36m-unsecured-convertible-promissory-note-to-investor-for-a-purchase-price-of-3m

On September 12, 2025 (the "Issue Date"), Glucotrack, Inc. (the "Company") entered into a Note Purchase Agreeme...

Core News & Articles

SMCI: 6% | Supermicro Launches Global Delivery Of NVIDIA Blackwell Ultra AI Systems For Scalable, Turnkey Deployment GCTK: 190%...

 glucotrack-enters-purchase-agreement-with-sixth-borough-capital-sixth-borough-capital-fund-commits-to-purchase-up-to-20m-of-cos-common-stock

-SEC Filing

 glucotrack-q2-eps-962-up-from-98400-yoy

GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(9.62) per share. This is a 99.02 percent increase over losses of $(984....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION